Hisun Pharm Hangzhou`s Generic Daptomycin Receives Approval In US
04 May 2021 //
FDA
Chipscreen and HISUN reach a strategic cooperation
16 Dec 2020 //
PRNEWSWIRE
Chipscreen and HISUN reach a strategic cooperation
16 Dec 2020 //
PRNEWSWIRE
The Lancet: Excellent Efficacy of Hisun`s Favipiravir Against COVID-19 Turkey
26 Aug 2020 //
PRNEWSWIRE
Hisun`s Favipiravir continuously supports the Middle East`s endeavor
29 Jul 2020 //
PRNEWSWIRE
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir
23 Jun 2020 //
PRNEWSWIRE
Hisun Pharm Hangzhou`s Generic Ticagrelor Receives Approval in US
23 Jan 2019 //
FDA
Hisun Pharm Hangzhou`s Generic Capreomycin Sulfate Receives Approval in US
24 Oct 2018 //
FDA
Hisun Pharm Hangzhou`s Generic Ticagrelor Receives Tentative Approval in US
19 Oct 2018 //
FDA
Brilinta (ticagrelor) : AstraZeneca UK et al v. Hisun Pharmaceutical
18 Aug 2018 //
PATENT LITIGATION
Hisun Pharm’s Generic Hydrochlorothiazide & Irbesartan Approved In US
14 Oct 2016 //
FDA